• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型冠状病毒血清学检测的研究进展综述

Review of Current Advances in Serologic Testing for COVID-19.

机构信息

Department of Hematology and Medical Oncology and University of Miami Miller School of Medicine and Jackson Health System, Miami, FL.

Department of Pathology and Laboratory Medicine, University of Miami Miller School of Medicine and Jackson Health System, Miami, FL.

出版信息

Am J Clin Pathol. 2020 Aug 5;154(3):293-304. doi: 10.1093/ajcp/aqaa112.

DOI:10.1093/ajcp/aqaa112
PMID:32583852
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7337672/
Abstract

OBJECTIVES

To examine and summarize the current literature on serologic methods for the detection of antibodies to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

METHODS

A literature review was performed using searches in databases including PubMed, medRxiv, and bioRxiv. Thirty-two peer-reviewed papers and 23 preprints were examined.

RESULTS

The studies included lateral flow immunoassay, enzyme-linked immunosorbent assay, chemiluminescence immunoassay, and neutralizing antibody assays. The use of all major SARS-CoV-2 antigens was demonstrated to have diagnostic value. Assays measuring total antibody reactivity had the highest sensitivity. In addition, all the methods provided opportunities to characterize the humoral immune response by isotype. The combined use of IgM and IgG detection resulted in a higher sensitivity than that observed when detecting either isotype alone. Although IgA was rarely studied, it was also demonstrated to be a sensitive marker of infection, and levels correlated with disease severity and neutralizing activity.

CONCLUSIONS

The use of serologic testing, in conjunction with reverse transcription polymerase chain reaction testing, was demonstrated to significantly increase the sensitivity of detection of patients infected with SARS-CoV-2. There was conflicting evidence regarding whether antibody titers correlated with clinical severity. However, preliminary investigations indicated some immunoassays may be a surrogate for the prediction of neutralizing antibody titers and the selection of recovered patients for convalescent serum donation.

摘要

目的

检查和总结目前关于严重急性呼吸综合征冠状病毒 2 (SARS-CoV-2) 抗体检测的血清学方法的文献。

方法

通过在 PubMed、medRxiv 和 bioRxiv 等数据库中进行检索,进行文献回顾。检查了 32 篇同行评议论文和 23 篇预印本。

结果

这些研究包括侧向流动免疫测定、酶联免疫吸附测定、化学发光免疫测定和中和抗体测定。证明使用所有主要的 SARS-CoV-2 抗原都具有诊断价值。检测总抗体反应性的测定具有最高的灵敏度。此外,所有方法都提供了通过同种型来描述体液免疫反应的机会。IgM 和 IgG 检测的联合使用比单独检测任何一种同种型的灵敏度都要高。虽然很少研究 IgA,但它也被证明是感染的敏感标志物,其水平与疾病严重程度和中和活性相关。

结论

血清学检测与逆转录聚合酶链反应检测联合使用,显著提高了检测 SARS-CoV-2 感染患者的灵敏度。抗体滴度与临床严重程度是否相关存在相互矛盾的证据。然而,初步研究表明,一些免疫测定可能是预测中和抗体滴度和选择恢复期患者进行恢复期血清捐献的替代指标。

相似文献

1
Review of Current Advances in Serologic Testing for COVID-19.新型冠状病毒血清学检测的研究进展综述
Am J Clin Pathol. 2020 Aug 5;154(3):293-304. doi: 10.1093/ajcp/aqaa112.
2
Assessment of SARS-CoV-2 serological tests for the diagnosis of COVID-19 through the evaluation of three immunoassays: Two automated immunoassays (Euroimmun and Abbott) and one rapid lateral flow immunoassay (NG Biotech).评估三种免疫测定法(Euroimmun 和 Abbott 的两种自动化免疫测定法以及 NG Biotech 的一种快速侧向流动免疫测定法)用于诊断 COVID-19 的 SARS-CoV-2 血清学检测。
J Clin Virol. 2020 Aug;129:104511. doi: 10.1016/j.jcv.2020.104511. Epub 2020 Jun 15.
3
Temporal Course of SARS-CoV-2 Antibody Positivity in Patients with COVID-19 following the First Clinical Presentation.首次临床症状出现后 COVID-19 患者 SARS-CoV-2 抗体阳性的时间过程。
Biomed Res Int. 2020 Nov 16;2020:9878453. doi: 10.1155/2020/9878453. eCollection 2020.
4
Quantification of SARS-CoV-2 antibodies with eight commercially available immunoassays.用八种市售免疫测定法定量 SARS-CoV-2 抗体。
J Clin Virol. 2020 Aug;129:104540. doi: 10.1016/j.jcv.2020.104540. Epub 2020 Jul 6.
5
Comparison of a rapid immunochromatographic test with a chemiluminescence immunoassay for detection of anti-SARS-CoV-2 IgM and IgG.快速免疫层析法与化学发光免疫分析法检测抗 SARS-CoV-2 IgM 和 IgG 的比较。
Biochem Med (Zagreb). 2020 Oct 15;30(3):030901. doi: 10.11613/BM.2020.030901.
6
Clinical and Analytical Performance of an Automated Serological Test That Identifies S1/S2-Neutralizing IgG in COVID-19 Patients Semiquantitatively.一种用于半定量识别 COVID-19 患者 S1/S2 中和 IgG 的自动化血清学检测的临床和分析性能。
J Clin Microbiol. 2020 Aug 24;58(9). doi: 10.1128/JCM.01224-20.
7
Four point-of-care lateral flow immunoassays for diagnosis of COVID-19 and for assessing dynamics of antibody responses to SARS-CoV-2.四种即时侧向流动免疫分析法,用于诊断 COVID-19 并评估针对 SARS-CoV-2 的抗体反应动态。
J Infect. 2020 Sep;81(3):435-442. doi: 10.1016/j.jinf.2020.06.023. Epub 2020 Jun 15.
8
COVID-19 and lombardy: TESTing the impact of the first wave of the pandemic.COVID-19 和伦巴第大区:测试大流行第一波的影响。
EBioMedicine. 2020 Nov;61:103069. doi: 10.1016/j.ebiom.2020.103069. Epub 2020 Oct 22.
9
Meta-analysis of diagnostic performance of serology tests for COVID-19: impact of assay design and post-symptom-onset intervals.COVID-19 血清学检测诊断性能的荟萃分析:检测设计和症状出现后时间间隔的影响。
Emerg Microbes Infect. 2020 Dec;9(1):2200-2211. doi: 10.1080/22221751.2020.1826362.
10
Severe Acute Respiratory Syndrome Coronavirus 2-Specific Antibody Responses in Coronavirus Disease Patients.严重急性呼吸综合征冠状病毒 2 特异性抗体反应在冠状病毒疾病患者中。
Emerg Infect Dis. 2020 Jul;26(7):1478-1488. doi: 10.3201/eid2607.200841. Epub 2020 Jun 21.

引用本文的文献

1
Development of Novel ssDNA Aptamers for Detection of Receptor-Binding Domain of SARS-COV‑2.用于检测新型冠状病毒受体结合域的新型单链DNA适配体的开发
ACS Omega. 2025 Jun 3;10(23):23981-23992. doi: 10.1021/acsomega.4c03580. eCollection 2025 Jun 17.
2
Combined with the semantic features of CT and selected clinical variables, a machine learning model for accurately predicting the prognosis of Omicron was established.结合CT的语义特征和选定的临床变量,建立了一种用于准确预测奥密克戎预后的机器学习模型。
BJR Open. 2024 Jun 5;7(1):tzae013. doi: 10.1093/bjro/tzae013. eCollection 2025 Jan.
3
Diagnostic Efficacy of 11 SARS-CoV-2 Serological Assays for COVID-19: A Meta-Analysis and Adjusted Indirect Comparison of Diagnostic Test Accuracy.11种新型冠状病毒2型血清学检测方法对冠状病毒病的诊断效能:诊断试验准确性的Meta分析和校正间接比较
Immun Inflamm Dis. 2024 Dec;12(12):e70114. doi: 10.1002/iid3.70114.
4
Addressing the antibody germline bias and its effect on language models for improved antibody design.解决抗体种系偏倚及其对改善抗体设计的语言模型的影响。
Bioinformatics. 2024 Nov 1;40(11). doi: 10.1093/bioinformatics/btae618.
5
Comprehensive phage display viral antibody profiling using VirScan: potential applications in chronic immune-mediated disease.使用 VirScan 进行全面的噬菌体展示病毒抗体分析:在慢性免疫介导性疾病中的潜在应用。
J Virol. 2024 Nov 19;98(11):e0110224. doi: 10.1128/jvi.01102-24. Epub 2024 Oct 21.
6
A SARS-CoV-2 minimum data standard to support national serology reporting.支持国家血清学报告的 SARS-CoV-2 最小数据标准。
Ann Clin Biochem. 2024 Nov;61(6):418-445. doi: 10.1177/00045632241261274. Epub 2024 Jun 17.
7
Potential of a Bead-Based Multiplex Assay for SARS-CoV-2 Antibody Detection.基于微珠的多重检测法用于检测新型冠状病毒2抗体的潜力
Biology (Basel). 2024 Apr 18;13(4):273. doi: 10.3390/biology13040273.
8
Plaque Reduction Neutralization Test (PRNT) Accuracy in Evaluating Humoral Immune Response to SARS-CoV-2.斑块减少中和试验(PRNT)在评估对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的体液免疫反应中的准确性
Diseases. 2024 Jan 18;12(1):29. doi: 10.3390/diseases12010029.
9
Sensitivities of a Rapid Test Versus an ELISA Kit for Detecting Anti-SARS-CoV-2 IgM/IgG in Sera from an Egyptian Cohort.一种快速检测试验与 ELISA 试剂盒检测埃及队列血清中抗 SARS-CoV-2 IgM/IgG 的敏感性比较。
Curr Microbiol. 2023 Nov 30;81(1):24. doi: 10.1007/s00284-023-03473-z.
10
The Patent and Literature Antibody Database (PLAbDab): an evolving reference set of functionally diverse, literature-annotated antibody sequences and structures.专利和文献抗体数据库(PLAbDab):一个不断发展的、具有多种功能的参考集,包含经过文献注释的抗体序列和结构。
Nucleic Acids Res. 2024 Jan 5;52(D1):D545-D551. doi: 10.1093/nar/gkad1056.

本文引用的文献

1
Clinical Significance of an IgM and IgG Test for Diagnosis of Highly Suspected COVID-19.用于诊断高度疑似新型冠状病毒肺炎的IgM和IgG检测的临床意义
Front Med (Lausanne). 2021 Apr 12;8:569266. doi: 10.3389/fmed.2021.569266. eCollection 2021.
2
COVID-19 antibody seroprevalence in Santa Clara County, California.加利福尼亚州圣克拉拉县的新冠病毒抗体血清流行率。
Int J Epidemiol. 2021 May 17;50(2):410-419. doi: 10.1093/ije/dyab010.
3
Serological detection of 2019-nCoV respond to the epidemic: A useful complement to nucleic acid testing.血清学检测 2019-nCoV 应对疫情:核酸检测的有益补充。
Int Immunopharmacol. 2020 Nov;88:106861. doi: 10.1016/j.intimp.2020.106861. Epub 2020 Jul 30.
4
Evaluations of the serological test in the diagnosis of 2019 novel coronavirus (SARS-CoV-2) infections during the COVID-19 outbreak.新型冠状病毒(SARS-CoV-2)感染的血清学检测在 COVID-19 疫情期间的诊断评估。
Eur J Clin Microbiol Infect Dis. 2020 Dec;39(12):2271-2277. doi: 10.1007/s10096-020-03978-6. Epub 2020 Jul 17.
5
SARS-CoV-2 proteome microarray for global profiling of COVID-19 specific IgG and IgM responses.SARS-CoV-2 蛋白组微阵列用于全面分析 COVID-19 特异性 IgG 和 IgM 反应。
Nat Commun. 2020 Jul 14;11(1):3581. doi: 10.1038/s41467-020-17488-8.
6
An evaluation of COVID-19 serological assays informs future diagnostics and exposure assessment.评估 COVID-19 血清学检测有助于未来的诊断和暴露评估。
Nat Commun. 2020 Jul 6;11(1):3436. doi: 10.1038/s41467-020-17317-y.
7
Diagnostic performance of seven rapid IgG/IgM antibody tests and the Euroimmun IgA/IgG ELISA in COVID-19 patients.在 COVID-19 患者中,七种快速 IgG/IgM 抗体检测试剂盒与 Euroimmun IgA/IgG ELISA 的诊断性能比较。
Clin Microbiol Infect. 2020 Aug;26(8):1082-1087. doi: 10.1016/j.cmi.2020.05.023. Epub 2020 May 28.
8
Performance of Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Assays in Different Stages of Infection: Comparison of Commercial Enzyme-Linked Immunosorbent Assays and Rapid Tests.新型严重急性呼吸综合征冠状病毒 2 抗体检测在感染不同阶段的表现:商业酶联免疫吸附测定法和快速检测的比较。
J Infect Dis. 2020 Jul 6;222(3):362-366. doi: 10.1093/infdis/jiaa305.
9
Antibody Tests in Detecting SARS-CoV-2 Infection: A Meta-Analysis.抗体检测在检测新型冠状病毒2019感染中的应用:一项荟萃分析
Diagnostics (Basel). 2020 May 19;10(5):319. doi: 10.3390/diagnostics10050319.
10
Serology characteristics of SARS-CoV-2 infection after exposure and post-symptom onset.感染 SARS-CoV-2 后的血清学特征:暴露后及症状出现后。
Eur Respir J. 2020 Aug 27;56(2). doi: 10.1183/13993003.00763-2020. Print 2020 Aug.